Expression Signature as a Biomarker for Prenatal Diagnosis of Trisomy 21

PLoS ONE - United States
doi 10.1371/journal.pone.0074184
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Fetal-Specific DNA Methylation Ratio Permits Noninvasive Prenatal Diagnosis of Trisomy 21

Obstetrical and Gynecological Survey
MedicineGynecologyObstetrics
2011English

Could Digital PCR Be an Alternative as a Non-Invasive Prenatal Test for Trisomy 21: A Proof of Concept Study

PLoS ONE
Multidisciplinary
2016English

A Clinical Metabolomics‑based Biomarker Signature as an Approach for Early Diagnosis of Gastric Cardia Adenocarcinoma

Oncology Letters
Cancer ResearchOncology
2019English

Controversies in Pregnancy Management After Prenatal Diagnosis of a Twin Pregnancy Discordant for Trisomy 21 Diagnosed by Cell-Free Fetal DNA Testing

SOJ Gynecology , Obstetrics & Women's Health
2017English

+21 or Trisomy 21

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Disease Specific Characteristics of Fetal Epigenetic Markers for Non-Invasive Prenatal Testing of Trisomy 21

BMC Medical Genomics
Genetics
2014English

Amniocentesis for Prenatal Diagnosis of Cytomegalovirus Infection: Challenging the 21 Weeks' Threshold

Prenatal Diagnosis
GynecologyGeneticsObstetrics
2017English

Prenatal Diagnosis of Ventricular Septal Defect and Trisomy 7q11.23q21.3 in Two Fetuses: A Case Report

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2018English

Prenatal Screening for Trisomy 18 With Free Beta Human Chorionic Gonadotrophin as a Marker.

BMJ
1993English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy